Wulf Siggelkow
Research Subjects
Wulf Siggelkow has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Marcus Schmidt
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
4 shared publications - Antje Lebrecht
Department of Obstetrics and Gynecology, University Medical Center Mainz, 55131 Mainz, Germany
3 shared publications - Heinz Koelbl
Department of Obstetrics and Gynecology, Johannes Gutenberg University, Mainz, Germany
3 shared publications Antonia Litz
1 shared publication- Birte Hellwig
Department of Statistics, TU Dortmund University, Dortmund, Germany
1 shared publication Christine Lindner
1 shared publication
Latest Publications
- Open Access
- 26 February 2014
- Published by Georg Thieme Verlag KG in Geburtshilfe und Frauenheilkunde
- Vol. 74 (02) , 146-151
Comparison of Obstetric Efficacy and Safety of the Kiwi OmniCup with Conventional Vacuum Extraction
Purpose: The aim of the present study was to compare the safety and efficacy of the Kiwi OmniCup system with conventional vacuum delivery. Methods: A retrospective study of operative vaginal deliveries was done for 4682 births. The procedures included 217 operative vaginal deliveries (4.6 %), 79 of which were done using conventional vacuum extraction (37 %) and 138 using the Kiwi system (63 %). Results: Use of the Kiwi system was associated with a significant reduction in episiotomies (61 vs. 76 % in the control group; p < 0.05). The rates of successful completion of birth were comparable for the two systems (94 % with the Kiwi system and 99 % with conventional vacuum delivery). Cup detachment occurred significantly more often in the Kiwi group (p < 0.005), requiring a change to a different method of birth significantly more often. It was necessary to change the procedure significantly more often from the mid-pelvis (p < 0.05). The incidence of maternal and foetal injuries was similar for the two systems. Conclusions: With regard to obstetric efficacy and safety and foetal and maternal injuries, the Kiwi system is an acceptable alternative to the conventional vacuum cup. The advantages of the Kiwi system are its significantly lower episiotomy rate and its ease and rapidity of use. Zielsetzung: In der vorliegenden Untersuchung werden die Sicherheit und Effektivität des Kiwi-OmniCup-Systems mit der konventionellen Vakuumentbindung verglichen. Methodik: Es wurde eine retrospektive Untersuchung vaginal-operativer Entbindungen aus einer Gesamtzahl von 4682 Geburten vorgenommen. Von diesen Patientinnen hatten 217 eine vaginal-operative Entbindung (4,6 %), davon 79 mithilfe konventioneller Vakuumextraktion (37 %) und 138 mit dem Kiwi-System (63 %). Ergebnisse: Der Einsatz des Kiwi-Systems ging mit einer signifikanten Reduktion der Episiotomien einher (61 vs. 76 % in der Kontrollgruppe, p < 0,05). Der Anteil erfolgreich zu Ende gebrachter Entbindungen war vergleichbar für beide Systeme (94 % mit dem Kiwi-System und 99 % mit konventioneller Vakuumentbindung). Ein Abreißen der Glocke trat signifikant häufiger in der Kiwi-Gruppe auf (p < 0,005) und zog somit signifikant häufiger den Wechsel auf einen anderen Geburtsmodus nach sich. Eine solche Notwendigkeit zum Verfahrenswechsel trat signifikant häufiger von der Beckenmitte auf (p < 0,05). Mütterliche wie kindliche Verletzungen traten in beiden Systemen mit gleicher Inzidenz auf. Schlussfolgerungen: Das Kiwi-System stellt hinsichtlich der geburtshilflichen Effektivität wie auch der Sicherheit im Hinblick auf fetale und mütterliche Verletzungen eine adäquate Alternative zur konventionellen Vakuumglocke dar. Das Kiwi-System sticht im Vergleich durch seine signifikant geringere Episiotomierate und die einfache und zügige Handhabung hervor.
- 26 February 2014
- Published by Georg Thieme Verlag KG in Geburtshilfe und Frauenheilkunde
- Vol. 74 (02) , 146-151
Open AccessComparison of Obstetric Efficacy and Safety of the Kiwi OmniCup with Conventional Vacuum Extraction
Purpose: The aim of the present study was to compare the safety and efficacy of the Kiwi OmniCup system with conventional vacuum delivery. Methods: A retrospective study of operative vaginal deliveries was done for 4682 births. The procedures included 217 operative vaginal deliveries (4.6 %), 79 of which were done using conventional vacuum extraction (37 %) and 138 using the Kiwi system (63 %). Results: Use of the Kiwi system was associated with a significant reduction in episiotomies (61 vs. 76 % in the control group; p < 0.05). The rates of successful completion of birth were comparable for the two systems (94 % with the Kiwi system and 99 % with conventional vacuum delivery). Cup detachment occurred significantly more often in the Kiwi group (p < 0.005), requiring a change to a different method of birth significantly more often. It was necessary to change the procedure significantly more often from the mid-pelvis (p < 0.05). The incidence of maternal and foetal injuries was similar for the two systems. Conclusions: With regard to obstetric efficacy and safety and foetal and maternal injuries, the Kiwi system is an acceptable alternative to the conventional vacuum cup. The advantages of the Kiwi system are its significantly lower episiotomy rate and its ease and rapidity of use. Zielsetzung: In der vorliegenden Untersuchung werden die Sicherheit und Effektivität des Kiwi-OmniCup-Systems mit der konventionellen Vakuumentbindung verglichen. Methodik: Es wurde eine retrospektive Untersuchung vaginal-operativer Entbindungen aus einer Gesamtzahl von 4682 Geburten vorgenommen. Von diesen Patientinnen hatten 217 eine vaginal-operative Entbindung (4,6 %), davon 79 mithilfe konventioneller Vakuumextraktion (37 %) und 138 mit dem Kiwi-System (63 %). Ergebnisse: Der Einsatz des Kiwi-Systems ging mit einer signifikanten Reduktion der Episiotomien einher (61 vs. 76 % in der Kontrollgruppe, p < 0,05). Der Anteil erfolgreich zu Ende gebrachter Entbindungen war vergleichbar für beide Systeme (94 % mit dem Kiwi-System und 99 % mit konventioneller Vakuumentbindung). Ein Abreißen der Glocke trat signifikant häufiger in der Kiwi-Gruppe auf (p < 0,005) und zog somit signifikant häufiger den Wechsel auf einen anderen Geburtsmodus nach sich. Eine solche Notwendigkeit zum Verfahrenswechsel trat signifikant häufiger von der Beckenmitte auf (p < 0,05). Mütterliche wie kindliche Verletzungen traten in beiden Systemen mit gleicher Inzidenz auf. Schlussfolgerungen: Das Kiwi-System stellt hinsichtlich der geburtshilflichen Effektivität wie auch der Sicherheit im Hinblick auf fetale und mütterliche Verletzungen eine adäquate Alternative zur konventionellen Vakuumglocke dar. Das Kiwi-System sticht im Vergleich durch seine signifikant geringere Episiotomierate und die einfache und zügige Handhabung hervor.
- Open Access
- 27 November 2012
- Published by Springer Nature in BMC Cancer
- Vol. 12 (1) , 562
Expression of aurora kinase A is associated with metastasis-free survival in node-negative breast cancer patients
Background: Inhibitors targeting the cell cycle-regulated aurora kinase A (AURKA) are currently being developed. Here, we examine the prognostic impact of AURKA in node-negative breast cancer patients without adjuvant systemic therapy (n = 766).Methods: AURKA was analyzed using microarray-based gene-expression data from three independent cohorts of node-negative breast cancer patients. In multivariate Cox analyses, the prognostic impact of age, histological grade, tumor size, estrogen receptor (ER), and HER2 were considered.Results: Patients with higher AURKA expression had a shorter metastasis-free survival (MFS) in the Mainz (HR 1.93; 95% CI 1.34 – 2.78; P < 0.001), Rotterdam (HR 1.95; 95% CI 1.45– 2.63; P<0.001) and Transbig (HR 1.52; 95% CI 1.14–2.04; P=0.005) cohorts. AURKA was also associated with MFS in the molecular subtype ER+/HER2- carcinomas (HR 2.10; 95% CI 1.70–2.59; P<0.001), but not in ER-/HER2- nor in HER2+ carcinomas. In the multivariate Cox regression adjusted to age, grade and tumor size, AURKA showed independent prognostic significance in the ER+/HER2- subtype (HR 1.73; 95% CI 1.24–2.42; P=0.001). Prognosis of patients in the highest quartile of AURKA expression was particularly poor. In addition, AURKA correlated with the proliferation metagene (R=0.880; P<0.001), showed a positive association with grade (P<0.001), tumor size (P<0.001) and HER2 (P<0.001), and was inversely associated with ER status (P75% percentile) have a particularly bad prognosis and may profit from therapy with AURKA inhibitors.
- 27 November 2012
- Published by Springer Nature in BMC Cancer
- Vol. 12 (1) , 562
Open AccessExpression of aurora kinase A is associated with metastasis-free survival in node-negative breast cancer patients
Background: Inhibitors targeting the cell cycle-regulated aurora kinase A (AURKA) are currently being developed. Here, we examine the prognostic impact of AURKA in node-negative breast cancer patients without adjuvant systemic therapy (n = 766).Methods: AURKA was analyzed using microarray-based gene-expression data from three independent cohorts of node-negative breast cancer patients. In multivariate Cox analyses, the prognostic impact of age, histological grade, tumor size, estrogen receptor (ER), and HER2 were considered.Results: Patients with higher AURKA expression had a shorter metastasis-free survival (MFS) in the Mainz (HR 1.93; 95% CI 1.34 – 2.78; P < 0.001), Rotterdam (HR 1.95; 95% CI 1.45– 2.63; P<0.001) and Transbig (HR 1.52; 95% CI 1.14–2.04; P=0.005) cohorts. AURKA was also associated with MFS in the molecular subtype ER+/HER2- carcinomas (HR 2.10; 95% CI 1.70–2.59; P<0.001), but not in ER-/HER2- nor in HER2+ carcinomas. In the multivariate Cox regression adjusted to age, grade and tumor size, AURKA showed independent prognostic significance in the ER+/HER2- subtype (HR 1.73; 95% CI 1.24–2.42; P=0.001). Prognosis of patients in the highest quartile of AURKA expression was particularly poor. In addition, AURKA correlated with the proliferation metagene (R=0.880; P<0.001), showed a positive association with grade (P<0.001), tumor size (P<0.001) and HER2 (P<0.001), and was inversely associated with ER status (P75% percentile) have a particularly bad prognosis and may profit from therapy with AURKA inhibitors.
- Open Access
- 31 July 2012
- Published by Georg Thieme Verlag KG in Geburtshilfe und Frauenheilkunde
- Vol. 72 (07) , 616-621
Skin-reducing Mastectomy with Primary Implant Reconstruction
Background: We present a series of skin-sparing mastectomies (SSMs) with skin reduction and immediate breast reconstruction to treat large and ptotic breasts. The technique combines oncological mastectomy with immediate subpectoral implant placement as a single-step procedure. Methods: Data was collected from a prospective database from February 2009 to April 2011. A total of 24 patients with macromastia or pronounced ptosis fulfilled the criteria for skin-saving mastectomy. All operations were carried out as a single-step procedure with adaptation of the contralateral breast by reduction mastopexy. Results: A total of 27 SSMs were performed in 24 patients. The mean implant volume was 265 cm3. Immediate reconstruction of the nipple-areola complex was done in 22 patients. The cosmetic and functional results were assessed in all patients 6 months postoperatively; mean follow-up time was 13 months. Mean patient age was 49 years. The cosmetic result was assessed as “very good” or “good” by 22 patients; 2 patients graded the result as “unsatisfactory”. There was one local recurrence. Conclusion: Our results support the use of this technique as a safe oncoplastic procedure which is well tolerated by patients. Hintergrund: Wir stellen die Ergebnisse einer Serie hautsparender Mastektomien mit Verkleinerung des Hautmantels und Sofortrekonstruktion für größere und ptotische Brüste vor. Diese ermöglicht in einer einzeitigen Operation sowohl eine onkologisch sichere Mastektomie wie auch eine sofortige implantatgestützte Wiederherstellung der Brust. Methoden: Wir präsentieren Daten einer prospektiven Datenbank unserer Kliniken von Februar 2009 bis April 2011. Insgesamt erfüllen 24 Patientinnen die Kriterien einer hautsparenden Mastektomie bei gleichzeitig bestehender Makromastie bzw. ausgeprägter Ptosis. Alle Operationen wurden unter Angleichung der Gegenseite mittels einer zentrokaudalen Reduktionsmastopexie einzeitig durchgeführt. Ergebnis: Es werden 27 hautsparende Mastektomien mit Implantat-Sofortrekonstruktion in 24 Patientinnen ausgewertet. Das durchschnittliche Implantatvolumen betrug 265 cm3. In 22 Patientinnen erfolgte eine Sofortrekonstruktion des Nippel-/Areolakomplexes. Eine Erfassung des kosmetischen und funktionellen Ergebnisses erfolgte bei allen Patientinnen 6 Monate nach OP, die mediane Nachbeobachtungszeit lag bei 13 Monaten. Das durchschnittliche Alter der Patientinnen lag bei 49 Jahren. Das kosmetische Ergebnis wurde von 22 Patientinnen als sehr gut bzw. gut empfunden, 2 Patientinnen empfanden das Ergebnis als unzulänglich. Es trat ein Lokalrezidiv im Hautweichteilmantel auf. Zusammenfassung: Im Ergebnis unserer Untersuchung ist die hautsparende Mastektomie unter Verkleinerung des Hautmantels mit einzeitiger Implantatrekonstruktion ein sicheres und von den Patientinnen gut akzeptiertes Verfahren.
- 31 July 2012
- Published by Georg Thieme Verlag KG in Geburtshilfe und Frauenheilkunde
- Vol. 72 (07) , 616-621
Open AccessSkin-reducing Mastectomy with Primary Implant Reconstruction
Background: We present a series of skin-sparing mastectomies (SSMs) with skin reduction and immediate breast reconstruction to treat large and ptotic breasts. The technique combines oncological mastectomy with immediate subpectoral implant placement as a single-step procedure. Methods: Data was collected from a prospective database from February 2009 to April 2011. A total of 24 patients with macromastia or pronounced ptosis fulfilled the criteria for skin-saving mastectomy. All operations were carried out as a single-step procedure with adaptation of the contralateral breast by reduction mastopexy. Results: A total of 27 SSMs were performed in 24 patients. The mean implant volume was 265 cm3. Immediate reconstruction of the nipple-areola complex was done in 22 patients. The cosmetic and functional results were assessed in all patients 6 months postoperatively; mean follow-up time was 13 months. Mean patient age was 49 years. The cosmetic result was assessed as “very good” or “good” by 22 patients; 2 patients graded the result as “unsatisfactory”. There was one local recurrence. Conclusion: Our results support the use of this technique as a safe oncoplastic procedure which is well tolerated by patients. Hintergrund: Wir stellen die Ergebnisse einer Serie hautsparender Mastektomien mit Verkleinerung des Hautmantels und Sofortrekonstruktion für größere und ptotische Brüste vor. Diese ermöglicht in einer einzeitigen Operation sowohl eine onkologisch sichere Mastektomie wie auch eine sofortige implantatgestützte Wiederherstellung der Brust. Methoden: Wir präsentieren Daten einer prospektiven Datenbank unserer Kliniken von Februar 2009 bis April 2011. Insgesamt erfüllen 24 Patientinnen die Kriterien einer hautsparenden Mastektomie bei gleichzeitig bestehender Makromastie bzw. ausgeprägter Ptosis. Alle Operationen wurden unter Angleichung der Gegenseite mittels einer zentrokaudalen Reduktionsmastopexie einzeitig durchgeführt. Ergebnis: Es werden 27 hautsparende Mastektomien mit Implantat-Sofortrekonstruktion in 24 Patientinnen ausgewertet. Das durchschnittliche Implantatvolumen betrug 265 cm3. In 22 Patientinnen erfolgte eine Sofortrekonstruktion des Nippel-/Areolakomplexes. Eine Erfassung des kosmetischen und funktionellen Ergebnisses erfolgte bei allen Patientinnen 6 Monate nach OP, die mediane Nachbeobachtungszeit lag bei 13 Monaten. Das durchschnittliche Alter der Patientinnen lag bei 49 Jahren. Das kosmetische Ergebnis wurde von 22 Patientinnen als sehr gut bzw. gut empfunden, 2 Patientinnen empfanden das Ergebnis als unzulänglich. Es trat ein Lokalrezidiv im Hautweichteilmantel auf. Zusammenfassung: Im Ergebnis unserer Untersuchung ist die hautsparende Mastektomie unter Verkleinerung des Hautmantels mit einzeitiger Implantatrekonstruktion ein sicheres und von den Patientinnen gut akzeptiertes Verfahren.
- 29 May 2008
- Vol. 28, 1207-11
Influence of resection volume on locoregional recurrence of breast cancer after breast-conserving surgery.
The goals of breast-conserving surgery are to provide the survival equivalent of mastectomy, a cosmetically acceptable breast and a low rate of locoregional recurrence in the treated breast. This retrospective study investigated the impact of the resection volume on locoregional recurrence after breast-conserving therapy in patients with early-stage invasive breast cancer. Retrospective data from 185 women who were treated for operable breast tumours by breast-conserving surgery between 1995-1999 at the Martin-Luther-University in Halle/Germany were included in our study. Extent of total resection volume (TRV), tumour volume (V) and difference volume (DV) was compared for the influence on locoregional recurrence. Our data showed no significant correlation between the risk of locoregional recurrence and the extent of resection volume. Predictors of an increased risk of locoregional recurrence after breast-conserving surgery were large primary tumour, grading, lymphatic vascular invasion, hormone receptor status and lack of radiotherapy or hormonal therapy. According to the accuracy of locoregional disease control and maintenance of the breast's shape, our results support conservative surgery in early-stage breast cancer followed by radiotherapy and adjuvant systemic therapy.
- 29 May 2008
- Vol. 28, 1207-11
Influence of resection volume on locoregional recurrence of breast cancer after breast-conserving surgery.
The goals of breast-conserving surgery are to provide the survival equivalent of mastectomy, a cosmetically acceptable breast and a low rate of locoregional recurrence in the treated breast. This retrospective study investigated the impact of the resection volume on locoregional recurrence after breast-conserving therapy in patients with early-stage invasive breast cancer. Retrospective data from 185 women who were treated for operable breast tumours by breast-conserving surgery between 1995-1999 at the Martin-Luther-University in Halle/Germany were included in our study. Extent of total resection volume (TRV), tumour volume (V) and difference volume (DV) was compared for the influence on locoregional recurrence. Our data showed no significant correlation between the risk of locoregional recurrence and the extent of resection volume. Predictors of an increased risk of locoregional recurrence after breast-conserving surgery were large primary tumour, grading, lymphatic vascular invasion, hormone receptor status and lack of radiotherapy or hormonal therapy. According to the accuracy of locoregional disease control and maintenance of the breast's shape, our results support conservative surgery in early-stage breast cancer followed by radiotherapy and adjuvant systemic therapy.
- 1 May 2007
- Vol. 27 (2) , 1223-6
Prognostic impact of haemoglobin levels in breast cancer.
Many patients with solid tumours suffer from anaemia, as a consequence of the disease itself or its treatment. Anaemia affects the quality of life and can have a negative impact on overall survival. The aim of the current study was to analyse the impact of haemoglobin levels on the prognosis of patients with primary breast cancer. Retrospective data from 249 women treated for operable breast tumours were included in our study. Haemoglobin (Hb) levels independently of anticancer therapy were compared for the prognostic influence on disease-free and overall survival. A significant correlation between higher minimum Hb level during chemotherapy and the disease-free and overall survival was found. Pre-treatment haemoglobin levels had no prognostic influence on the disease-free and overall survival. The present data showed that anaemia during adjuvant chemotherapy to be a negative prognostic indicator for survival of patients with breast cancer.
- 1 May 2007
- Vol. 27 (2) , 1223-6
Prognostic impact of haemoglobin levels in breast cancer.
Many patients with solid tumours suffer from anaemia, as a consequence of the disease itself or its treatment. Anaemia affects the quality of life and can have a negative impact on overall survival. The aim of the current study was to analyse the impact of haemoglobin levels on the prognosis of patients with primary breast cancer. Retrospective data from 249 women treated for operable breast tumours were included in our study. Haemoglobin (Hb) levels independently of anticancer therapy were compared for the prognostic influence on disease-free and overall survival. A significant correlation between higher minimum Hb level during chemotherapy and the disease-free and overall survival was found. Pre-treatment haemoglobin levels had no prognostic influence on the disease-free and overall survival. The present data showed that anaemia during adjuvant chemotherapy to be a negative prognostic indicator for survival of patients with breast cancer.